Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients

British Journal of Cancer

Volumn 109, Issue 4, 2013, Pages 1023-1030

  Candy, P A ^a,b   Phillips, M R ^b   Redfern, A D ^a,b,c   Colley, S M ^a,b   Davidson, J A ^b,c   Stuart, L M ^a,b   Wood, B A ^d   Zeps, N ^e   Leedman, P J ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

^d PATHWEST LABORATORY MEDICINE   (Australia)

^e ST JOHN OF GOD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; NOTCH INDUCED TRANSCRIPTION FACTOR; NOTCH RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR HEY 1; TRANSCRIPTION FACTOR SOX9; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PATIENT SELECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; TISSUE MICROARRAY; TREATMENT RESPONSE; TUMOR INVASION;

ANTIMETABOLITES, ANTINEOPLASTIC; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HOMEODOMAIN PROTEINS; HUMANS; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84883188923     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.431     Document Type: Article

References (54)

1. Bastide P, Darido C, Pannequin J, Kist R, Robine S, Marty-Double C, Bibeau F, Scherer G, Joubert D, Hollande F, Blache P, Jay P (2007) Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium. J Cell Biol 178(4): 635-648.
2. Belandia B, Powell SM, Garcia-Pedrero JM, Walker MM, Bevan CL, Parker MG (2005) Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Mol Cell Biol 25(4): 1425-1436.
3. Chai SM, Zeps N, Shearwood A-M, Grieu F, Charles A, Harvey J, Goldblatt J, Joseph D, Iacopetta B (2004) Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients. Clin Gastroenterol Hepatol 2(11): 1017-1025.
4. Clark-Langone KM, Sangli C, Krishnakumar J, Watson D (2010) Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer Assay. BMC Cancer 10(691): 691.
5. DeVita V, Lawrence T, Rosenburg S, DePinho R, Weinberg R (2008) DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. Lippincott Williams & Wilkins.
6. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, DiMeco F, Piccirillo S, Vescovi AL, Eberhart CG (2010) NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28(1): 5-16.
7. Feng Han Q, Zhao W, Bentel J, Shearwood A-M, Zeps N, Joseph D, Iacopetta B, Dharmarajan A (2006) Expression of sFRP-4 and [beta]-catenin in human colorectal carcinoma. Cancer Letts 231(1): 129-137.
8. Fischer A, Steidl C, Wagner TU, Lang E, Jakob PM, Friedl P, Knobeloch K-P, Gessler M (2007) Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circulation Res 100(6): 856-863.
9. Garcia A, Kandel JJ (2012) Notch: A key regulator of tumor angiogenesis and metastasis. Histol Histopathol 27(2): 151-156.
10. Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81(3): 515-526.
11. Gunther K, Brabletz T, Kraus C, Dworak O, Reymond M, Jung A, Hohenberger W, Kirchner T, Kockerling F, Ballhausen W (1998) Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer. Dis Colon Rectum 41(10): 1256-1261.
12. Harrell FE (2011) rms: regression modeling strategies. R Package Version 3: 3-3.
13. Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. J Am Med Assoc 247: 2543-2546.
14. Huang Q, Raya A, DeJesus P, Chao S-H, Quon KC, Caldwell JS, Chanda SK, Izpisua-Belmonte JC, Schultz PG (2004) Identification of p53 regulators by genome-wide functional analysis. Proc Natl Acad Sci USA 101(10): 3456-3461.
15. Hughes DP (2009) How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize. Cancer Treat Res 152: 479-496.
16. Hulleman E, Quarto M, Vernell R, Masserdotti G, Colli E, Kros JM, Levi D, Gaetani P, Tunici P, Finocchiaro G, RRy Baena, Capra M, Helin K (2009) A role for the transcription factor HEY1 in glioblastoma. J Cell Mol Med 13(1): 136-146.
17. Izrailit J, Reedijk M (2012) Developmental pathways in breast cancer and breast tumor-initiating cells: Therapeutic implications. Cancer Letts 317(2): 115-126.
18. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2): 69-90.
19. Jin HY, Xu JH, Wang XF, Ding YJ (2011) Expression pattern and clinical significance of hairy enhancer of split 1 in colorectal cancer. Zhonghua Yi Xue Za Zhi 91(41): 2891-2894.
20. Kannan S, Fang W, Song G, Mullighan CG, Hammitt R, McMurray J, Zweidler-McKay PA (2011) Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression. Blood 117(10): 2891-2900.
21. Kunnimalaiyaan M, Traeger K, Chen H (2005) Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells. Am J Physiol Gastrointestinal Liver Physiol 289(4): G636-G642.
22. Li FY, Lai MD (2009) Colorectal cancer, one entity or three. J Zhejiang Univ Sci B 10(3): 219-229.
23. Lü B, Fang Y, Xu J, Wang L, Xu F, Xu E, Huang Q, Lai M (2008) Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol 130(6): 897-904.
24. Maier MM, Gessler M (2000) Comparative analysis of the human and mouse Hey1 promoter: Hey genes are new notch target genes. Biochem Biophys Res Commun 275(2): 652-660.
25. Maniati E, Bossard M, Cook N, Candido J, Emami-Shahri N, Nedospasov S, Balkwill F, Tuveson D, Hagemann T (2011) Crosstalk between the canonical NF-kappaB and Notch signaling pathways inhibits Ppargamma expression and promotes pancreatic cancer progression in mice. J Clin Invest 121(12): 4685-4699.
26. Mann CD, Bastianpillai C, Neal CP, Masood MM, Jones DJ, Teichert F, Singh R, Karpova E, Berry DP, Manson MM (2012) Notch3 and hey-1 as prognostic biomarkers in pancreatic adenocarcinoma. PLoS One 7(12): e51119.
27. Matheu A, Collado M, Wise C, Manterola L, Cekaite L, Tye AJ, Canamero M, Bujanda L, Schedl A, Cheah KSE, Skotheim RI, Lothe RA, Lopez de Munain A, Briscoe J, Serrano M, Lovell-Badge R (2012) Oncogenicity of the developmental transcription factor Sox9. Cancer Res 72: 1301-1315.
28. Mazur PK, Riener M-O, Jochum W, Kristiansen G, Weber A, Schmid RM, Siveke JT (2012) Expression and clinicopathological significance of Notch signaling and cell-fate genes in biliary tract cancer. Am J Gastroenterol 107(1): 126-135.
29. Meng RD, Shelton CC, Li Y-M, Qin L-X, Notterman D, Paty PB, Schwartz GK (2009) g-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res 69(2): 573-582.
30. Minoo P, Zlobec I, Peterson M, Terracciano L, Lugli A (2010) Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int J Oncol 37(3): 707-718.
31. Miyamoto S, Rosenberg DW (2011) Role of Notch signaling in colon homeostasis and carcinogenesis. Cancer Sci 102(11): 1938-1942.
32. Morikawa T, Kuchiba A, Yamauchi M, Meyerhardt JA, Shima K, Nosho K, Chan AT, Giovannucci E, Fuchs CS, Ogino S (2011) Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA 305(16): 1685-1694.
33. Muto A, Iida A, Satoh S, Watanabe S (2009) The group E Sox genes Sox8 and Sox9 are regulated by Notch signaling and are required for Müller glial cell development in mouse retina. Exp Eye Res 89(4): 549-558.
34. Müller P, Crofts J, Newman B, Bridgewater L, Lin C-Y, Gustafsson J-Å, Ström A (2010) SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells. Breast Cancer Res Treat 120(2): 317-326.
35. Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I, Maric D, Eberhart CG, Fine HA (2005) Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 65(6): 2353-2363.
36. Reedijk MOS, Zhang H, Chetty R, Tennert C, Dickson BC, Lockwood G, Gallinger SES (2008) Activation of Notch signaling in human colon adenocarcinoma. Int J Oncol 33(6): 1223-1229.
37. Sakamoto M, Hirata H, Ohtsuka T, Bessho Y, Kageyama R (2003) The basic helix-loop-helix genes Hesr1/Hey1 and Hesr2/Hey2 regulate maintenance of neural precursor cells in the brain. J Biol Chem 278(45): 44808-44815.
38. Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B (2009) Tumor-infiltrating FOXP3\+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27(2): 186-192.
39. Schreck KC, Taylor P, Marchionni L, Gopalakrishnan V, Bar EE, Gaiano N, Eberhart CG (2010) The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance. Clin Cancer Res 16(24): 6060-6070.
40. Shirasaka T, Taguchi T (2006) Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept. Gan To Kagaku Ryoho 33(Suppl 1): 4-18.
41. Staal FJT, Langerak AW (2008) Signaling pathways involved in the development of T-cell acute lymphoblastic leukemia. Haematologica 93(4): 493-497.
42. Strosberg JR, Yeatman T, Weber J, Coppola D, Schell MJ, Han G, Almhanna K, Kim R, Valone T, Jump H, Sullivan D (2012) A phase II study of RO4929097 in metastatic colorectal cancer. Eur J Cancer 48(7): 997-1003.
43. Tseng YC, Tsai YH, Tseng MJ, Hsu KW, Yang MC, Huang KH, Li AF, Chi CW, Hsieh RH, Ku HH, Yeh TS (2012) Notch2-induced COX-2 expression enhancing gastric cancer progression. Mol Carcinog 51(12): 939-951.
44. Ueo T, Imayoshi I, Kobayashi T, Ohtsuka T, Seno H, Nakase H, Chiba T, Kageyama R (2012) The role of Hes genes in intestinal development, homeostasis and tumor formation. Development 139: 1071-1082.
45. Villaronga MA, Lavery DN, Bevan CL, Llanos S, Belandia B (2009) HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions. Oncogene 29(3): 411-420.
46. Wang H, Tian Y, Wang J, Phillips K, Binch A, Dunn S, Cross A, Chiverton N, Zheng Z, Shapiro I, Le Maitre C, Risbud M (2013) Inflammatory cytokines induce NOTCH signaling in nucleus pulposus cells: implications in intervertebral disc degeneration. J Biol Chem 288(23): 16761-16774.
47. Wang X, Fu Y, Chen X, Ye J, Lü B, Ye F, Lü W, Xie X (2010) The expressions of bHLH gene HES1 and HES5 in advanced ovarian serous adenocarcinomas and their prognostic significance: a retrospective clinical study. J Cancer Res Clin Oncol 136(7): 989-996.
48. Xie M, Zhang L, He C-S, Xu F, Liu J-L, Hu Z-H, Zhao L-P, Tian Y (2011) Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-Acquired resistant lung cancer cells. J Cell Biochem 113: 1501-1513.
49. Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14(6): 818-829.
50. Zage PE, Nolo R, Fang W, Stewart J, Garcia-Manero G, Zweidler-McKay PA (2011) Notch pathway activation induces neuroblastoma tumor cell growth arrest. Pediatr Blood Cancer 58: 682-689.
51. Zamurovic N, Cappellen D, Rohner D, Susa M (2004) Coordinated activation of Notch, Wnt, and transforming growth factor-b signaling pathways in Bone Morphogenic Protein 2-induced osteogenesis. J Biol Chem 279(36): 37704-37715.
52. Zhang X, Chen T, Zhang J, Mao Q, Li S, Xiong W, Qiu Y, Xie Q, Ge J (2011) Notch1 promotes glioma cell migration and invasion by stimulating b-catenin and NF-kB signaling via AKT activation. Cancer Sci 103: 181-190.
53. Zhou C-J, Guo J-Q, Zhu K-X, Zhang Q-H, Pan C-R, Xu W-H, Wang H-J, Liu B (2011) Elevated expression of SOX9 is related with the progression of gastric carcinoma. Diagnost Cytopathol 39(2): 105-109.
54. Zhou L, Wang DS, Li QJ, Sun W, Zhang Y, Dou KF (2012) The downregulation of Notch1 inhibits the invasion and migration of hepatocellular carcinoma cells by inactivating the Cyclooxygenase-2/Snail/E-cadherin pathway in vitro. Dig Dis Sci 7: 7.